Processing Your Payment

Please do not leave this page until complete. This can take a few moments.

November 12, 2015

Boston Scientific to pay $70M for Texas company

Courtesy Photos Marlborough-based Boston Scientific will expand its cancer treatment offerings with the $70 million purchase of a Texas company.

Marlborough-based Boston Scientific will expand its cancer treatment portfolio with the $70 million purchase of a portion of Texas-based CeloNova Biosciences.

Boston Scientific will make an upfront payment of $70 million for CeloNova’s interventional radiology business, according to a statement from Boston Scientific. The San Antonio-based CeloNova is a medical device company that develops endovascular and interventional cardiology technologies.

The agreement includes drug-eluting microspheres designed to be loaded with chemotherapy drugs for delivery to cancerous tumors, Boston Scientific said, as well as other cancer-treatment delivery devices. These devices will fuel growth of Boston Scientific’s cancer solutions, especially in emerging markets, according to Jeff Mirviss, head of Boston Scientific’s Peripheral Interventions division, said in a statement.

The significant clinical scale and commercial reach of Boston Scientific will help expand the value of these innovative technologies, CeloNova BioSciences President and CEO Martin J. Landon said in a statement, bringing the benefits of these therapies to more patients around the world.

Payments in addition to the $70 million will be contingent on regulatory and sales milestones, according to Boston Scientific.

Sign up for Enews

WBJ Web Partners

Related Content

0 Comments

Register for free to read more articles.

Register Now

Already have an online account? Login

To ensure the best experience on our website, articles cannot be read without allowing cookies. Please allow cookies to continue reading. Our privacy policy

Allow Cookies